Objective:The aim of this study was to investigate the underlying mechanism whereby HBx modulates the targeting ofNUSAP1 bymiR-18b to enhance hepatocarcinogenes
Objective:Cancer vaccines that rely on tumor antigen-specific CD8+ T cell responses, are promising anti-cancer adjuvant immunotherapies. This study investigated